PEGFILGRASTIM-APGF

PEGFILGRASTIM-APGF was reported 198 times

PEGFILGRASTIM-APGF is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MALIGNANT NIPPLE NEOPLASM 1 0.1111
1 PERIORBITAL INFLAMMATION 1 0.0043
2 ACCIDENTAL EXPOSURE TO PRODUCT PACKAGING 1 0.0042
3 HYPERCALCAEMIA OF MALIGNANCY 1 0.0037
4 COLON CANCER STAGE IV 2 0.0034
5 NECROSIS ISCHAEMIC 1 0.0022
6 DEVICE SAFETY FEATURE ISSUE 2 0.0020
7 HYPERSENSITIVITY PNEUMONITIS 2 0.0018
8 DEVICE OPERATIONAL ISSUE 6 0.0014
9 DENTAL RESTORATION FAILURE 1 0.0014
10 ADENOCARCINOMA GASTRIC 1 0.0011
11 BLADDER CATHETERISATION 1 0.0010
12 TONSILLAR DISORDER 1 0.0009
13 PALMAR ERYTHEMA 1 0.0009
14 ENDOCRINE DISORDER 1 0.0008
15 TUMOUR PAIN 1 0.0008
16 ANAL HAEMORRHAGE 2 0.0007
17 INJECTION RELATED REACTION 1 0.0006
18 LEUKAEMIA RECURRENT 1 0.0006
19 FEMALE GENITAL TRACT FISTULA 1 0.0006
20 FOOD INTERACTION 1 0.0006
21 VULVOVAGINAL SWELLING 1 0.0005
22 NAIL DISCOLOURATION 2 0.0005
23 DEVICE CONNECTION ISSUE 1 0.0005
24 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 1 0.0004
25 GASTROINTESTINAL TUBE INSERTION 1 0.0004
26 ILEOSTOMY 1 0.0004
27 CANCER PAIN 1 0.0004
28 ABDOMINAL RIGIDITY 1 0.0004
29 STOMA SITE DISCHARGE 1 0.0004
30 ATYPICAL PNEUMONIA 1 0.0003
31 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1 0.0003
32 WOUND DEHISCENCE 1 0.0003
33 B-CELL LYMPHOMA 1 0.0003
34 FULL BLOOD COUNT ABNORMAL 3 0.0003
35 CHEMOTHERAPY 1 0.0003
36 DEVICE LEAKAGE 11 0.0003
37 BLOOD DISORDER 2 0.0002
38 RECURRENT CANCER 1 0.0002
39 LEG AMPUTATION 1 0.0002
40 BONE CANCER 1 0.0002
41 NAIL DISORDER 2 0.0002
42 IMMUNOSUPPRESSION 2 0.0002
43 MYOSITIS 2 0.0002
44 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
45 NEUTROPHIL COUNT INCREASED 2 0.0002
46 DEVICE DEFECTIVE 3 0.0002
47 NEEDLE ISSUE 5 0.0002
48 POLYNEUROPATHY 2 0.0002
49 DEVICE DEPLOYMENT ISSUE 2 0.0002
50 OCCUPATIONAL EXPOSURE TO PRODUCT 1 0.0002
51 DRUG DOSE OMISSION BY DEVICE 12 0.0002
52 FULL BLOOD COUNT DECREASED 3 0.0001
53 METASTASES TO LYMPH NODES 1 0.0001
54 PSYCHIATRIC SYMPTOM 1 0.0001
55 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
56 PANCREATITIS ACUTE 3 0.0001
57 DEVICE PHYSICAL PROPERTY ISSUE 1 0.0001
58 DIFFUSE LARGE B-CELL LYMPHOMA 1 0.0001
59 CONCUSSION 1 0.0001
60 FRUSTRATION TOLERANCE DECREASED 1 0.0001
61 SENSATION OF FOREIGN BODY 1 0.0001
62 PSYCHOLOGICAL TRAUMA 1 0.0001
63 EXPOSURE VIA SKIN CONTACT 3 0.0001
64 HEAD DISCOMFORT 2 0.0001
65 ANAL INCONTINENCE 1 0.0001
66 BRAIN NEOPLASM 1 0.0001
67 PRODUCT PACKAGING ISSUE 1 0.0001
68 HOSPICE CARE 1 0.0001
69 POOR QUALITY DEVICE USED 1 0.0001
70 DRUG LEVEL DECREASED 1 0.0001
71 INJURY ASSOCIATED WITH DEVICE 2 0.0001
72 TRANSFUSION 1 0.0001
73 BREAST CANCER METASTATIC 1 0.0001
74 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
75 MALNUTRITION 1 0.0001
76 ELECTROLYTE IMBALANCE 1 0.0001
77 VASCULITIS 1 0.0001
78 LOCALISED INFECTION 2 0.0001
79 IMMUNE SYSTEM DISORDER 1 0.0001
80 NEOPLASM MALIGNANT 5 0.0001
81 QUALITY OF LIFE DECREASED 1 0.0001
82 DEVICE BREAKAGE 3 0.0001
83 DEVICE MECHANICAL ISSUE 1 0.0001
84 APHONIA 1 0.0001
85 DEVICE OCCLUSION 1 0.0001
86 SKIN REACTION 1 0.0001
87 DEVICE ISSUE 6 0.0001
88 DEVICE RELATED INFECTION 1 0.0001
89 LYMPHOMA 1 0.0001
90 TENDONITIS 1 0.0001
91 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 3 0.0001
92 BRAIN FOG 1 0.0001
93 FEBRILE NEUTROPENIA 4 0.0001
94 DEVICE USE ERROR 2 0.0001
95 DEVICE USE ISSUE 1 0.0001
96 SYRINGE ISSUE 1 0.0001
97 HYPOXIA 2 0.0001
98 AGRANULOCYTOSIS 1 0.0001
99 THINKING ABNORMAL 1 0.0001
100 COLITIS 2 0.0001
101 NEUTROPENIA 7 0.0001
102 BONE PAIN 3 0.0001
103 DYSPEPSIA 5 0.0001
104 CYTOKINE RELEASE SYNDROME 1 0.0000
105 PRODUCT PHYSICAL ISSUE 1 0.0000
106 FEEDING DISORDER 1 0.0000
107 ILLNESS 5 0.0000
108 EATING DISORDER 1 0.0000
109 WHITE BLOOD CELL COUNT DECREASED 5 0.0000
110 PYREXIA 15 0.0000
111 COGNITIVE DISORDER 2 0.0000
112 PRODUCT PRESCRIBING ERROR 1 0.0000
113 MENTAL IMPAIRMENT 1 0.0000
114 DYSGEUSIA 3 0.0000
115 AGEUSIA 1 0.0000
116 HYPOPHAGIA 1 0.0000
117 HOSPITALISATION 6 0.0000
118 ACCIDENTAL EXPOSURE TO PRODUCT 4 0.0000
119 INCORRECT DOSE ADMINISTERED BY DEVICE 1 0.0000
120 BREAST CANCER FEMALE 1 0.0000
121 DEVICE DELIVERY SYSTEM ISSUE 1 0.0000
122 INTENTIONAL DOSE OMISSION 1 0.0000
123 DYSSTASIA 1 0.0000
124 PALPITATIONS 4 0.0000
125 LABORATORY TEST ABNORMAL 1 0.0000
126 DISCOMFORT 2 0.0000
127 HEAD INJURY 1 0.0000
128 NEUROPATHY PERIPHERAL 3 0.0000
129 CYSTITIS 1 0.0000
130 MOVEMENT DISORDER 1 0.0000
131 CHOLELITHIASIS 1 0.0000
132 EYE DISORDER 1 0.0000
133 STAPHYLOCOCCAL INFECTION 1 0.0000
134 HEART RATE INCREASED 3 0.0000
135 GAIT INABILITY 1 0.0000
136 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
137 HAEMOGLOBIN DECREASED 3 0.0000
138 NEOPLASM PROGRESSION 1 0.0000
139 CRYING 1 0.0000
140 AGITATION 2 0.0000
141 EPISTAXIS 2 0.0000
142 DEATH 23 0.0000
143 DYSPNOEA EXERTIONAL 1 0.0000
144 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
145 DRY MOUTH 2 0.0000
146 BLINDNESS 1 0.0000
147 NEUTROPHIL COUNT DECREASED 1 0.0000
148 ASTHENIA 9 0.0000
149 HYPERHIDROSIS 3 0.0000
150 RECTAL HAEMORRHAGE 1 0.0000
151 ANGIOEDEMA 1 0.0000
152 TACHYCARDIA 2 0.0000
153 COLITIS ULCERATIVE 1 0.0000
154 SKIN DISCOLOURATION 1 0.0000
155 DECREASED APPETITE 5 0.0000
156 DISEASE RECURRENCE 1 0.0000
157 ANAEMIA 4 0.0000
158 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
159 INFECTION 3 0.0000
160 SOMNOLENCE 4 0.0000
161 CELLULITIS 1 0.0000
162 FLUSHING 2 0.0000
163 OFF LABEL USE 17 0.0000
164 NERVOUSNESS 1 0.0000
165 PLATELET COUNT DECREASED 2 0.0000
166 HAEMATOCHEZIA 1 0.0000
167 INFLUENZA 2 0.0000
168 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
169 ABDOMINAL PAIN 4 0.0000
170 DYSPHONIA 1 0.0000
171 SURGERY 1 0.0000
172 PLEURAL EFFUSION 1 0.0000
173 OEDEMA PERIPHERAL 2 0.0000
174 DEEP VEIN THROMBOSIS 1 0.0000
175 DEHYDRATION 2 0.0000
176 DRY SKIN 2 0.0000
177 HYPOTENSION 3 0.0000
178 DEVICE MALFUNCTION 1 0.0000
179 SLEEP DISORDER 1 0.0000
180 THERAPY INTERRUPTED 1 0.0000
181 SKIN BURNING SENSATION 1 0.0000
182 NAUSEA 11 0.0000
183 UNDERDOSE 1 0.0000
184 HOT FLUSH 1 0.0000
185 FATIGUE 10 0.0000
186 THROMBOSIS 1 0.0000
187 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
188 GASTROINTESTINAL DISORDER 1 0.0000
189 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
190 NO ADVERSE EVENT 2 0.0000
191 ADVERSE EVENT 1 0.0000
192 DIARRHOEA 7 0.0000
193 HYPERSENSITIVITY 2 0.0000
194 WEIGHT DECREASED 3 0.0000
195 BREAST CANCER 1 0.0000
196 COUGH 3 0.0000
197 SWELLING 1 0.0000
198 MIGRAINE 1 0.0000
199 PRURITUS 4 0.0000
200 ALOPECIA 2 0.0000
201 CHEST DISCOMFORT 1 0.0000
202 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
203 ABDOMINAL DISTENSION 1 0.0000
204 PNEUMONIA 3 0.0000
205 RASH 4 0.0000
206 CONSTIPATION 2 0.0000
207 MALAISE 4 0.0000
208 THROMBOCYTOPENIA 1 0.0000
209 BACK PAIN 2 0.0000
210 FEELING ABNORMAL 2 0.0000
211 VISUAL IMPAIRMENT 1 0.0000
212 MEMORY IMPAIRMENT 1 0.0000
213 PAIN IN EXTREMITY 2 0.0000
214 BLOOD PRESSURE INCREASED 1 0.0000
215 DIZZINESS 3 0.0000
216 URTICARIA 1 0.0000
217 CEREBROVASCULAR ACCIDENT 1 0.0000
218 MYOCARDIAL INFARCTION 1 0.0000
219 COVID-19 1 0.0000
220 CHEST PAIN 1 0.0000
221 DYSPNOEA 3 0.0000
222 GAIT DISTURBANCE 1 0.0000
223 ERYTHEMA 1 0.0000
224 ABDOMINAL PAIN UPPER 1 0.0000
225 HEADACHE 3 0.0000
226 HYPERTENSION 1 0.0000
227 VOMITING 2 0.0000
228 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
229 PAIN 2 0.0000
230 FALL 1 0.0000
231 ARTHRALGIA 1 0.0000
232 DRUG INEFFECTIVE 3 0.0000